Ekso Bionics Announces 1-For-7 Reverse Stock Split In Preparation For Proposed Uplisting To Nasdaq
May 04, 2016 at 19:38 PM EDT
The company believes that it currently meets all of the listing requirements for listing the company’s common stock on the Nasdaq Capital Market other than the minimum trading price requirement.
